Search results for: 'partnering agreements with 3sbio 221b 2004'
- Did you mean
- partnering agreements with 3sbio 2016 2025
- Related search terms
- partnering agreements with base 2010 2010
- partnering agreements with biomark pharmaceuticals 2025 2016
- partnering agreements with activ 2004 2004
- partnering agreements with new therapeutic 2020 2016
- partnering agreements with action 2020 2016
-
Distribution Deals in Pharmaceuticals and Biotechnology 2020 to 2026March 2026$3,995.00Distribution Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2026
Learn More -
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2026March 2026$3,995.00Track JV activity across pharma and biotech with real-world examples, financial terms, and partnering trends—includes access to contract documents where available.
Learn More -
Gene Editing Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Gene Editing Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Molecular Diagnostics Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Molecular Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Diagnostic Collaboration and Licensing Deals 2020-2025May 2025$4,995.00Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2020 to 2025
Learn More -
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Monoclonal Antibody Collaboration and Licensing Deals 2019-2025November 2025$3,995.00Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Distribution Deals in Diagnostics 2016-2026March 2026$3,995.00Distribution Deals in Diagnostics | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2026
Learn More -
Cell Therapy Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Cell Therapy Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Royalty Rates in Pharmaceutical and Biotechnology Deals 2015 to 2026March 2026$4,995.00Essential Benchmark Data for Dealmakers | Global coverage | Updated to 2026 | 11+ years of royalty rates | Deal financials | Contract documents | Royalty rate trends
Learn More
- Category CP Reports Store Remove This Item
